TMIGD1

TMIGD1
Identifiers
Aliases	TMIGD1, TMIGD, UNQ9372, transmembrane and immunoglobulin domain containing 1
External IDs	MGI: 1913851 HomoloGene: 41641 GeneCards: TMIGD1
Gene location (Human)
Chr.	Chromosome 17 (human)[1]
End	30,334,059 bp[1]
Gene location (Mouse)
Chr.	Chromosome 11 (mouse)[2]
End	76,807,413 bp[2]
RNA expression pattern
	Top expressed in
	rectum; ; kidney; ; smooth muscle tissue; ; duodenum; ; appendix; ; renal cortex; ; lymph node; ; islet of Langerhans; ; body of stomach; ; fundus;
	Top expressed in
	intestinal villus; ; kidney; ; ileum; ; Paneth cell; ; proximal tubule; ; jejunum; ; esophagus; ; submandibular gland; ; conjunctival fornix; ; parotid gland;
	More reference expression data
	n/a
Orthologs
	388364
	66601
	ENSG00000182271
	ENSMUSG00000020839
	Q6UXZ0
	Q9D7L8
	NM_206832; NM_001319942
	NM_025655; NM_001382246; NM_001382247
	NP_001306871; NP_996663
	NP_079931; NP_001369175; NP_001369176
	Wikidata
View/Edit Human	View/Edit Mouse

Transmembrane and immunoglobulin domain containing 1 is a protein that in humans is encoded by the TMIGD1 gene.[5] TMIGD1 was discovered by Nader Rahimi.[6][7]

References

GRCh38: Ensembl release 89: ENSG00000182271 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000020839 - Ensembl, May 2017
"Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
"Entrez Gene: Transmembrane and immunoglobulin domain containing 1". Retrieved 2017-02-20.
Meyer RD, Zou X, Ali M, Ersoy E, Bondzie PA, Lavaei M, et al. (February 2018). "TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer". Oncotarget. 9 (11): 9672–9684. doi:10.18632/oncotarget.23822. PMC 5839393. PMID 29515762.
Arafa E, Bondzie PA, Rezazadeh K, Meyer RD, Hartsough E, Henderson JM, et al. (October 2015). "TMIGD1 is a novel adhesion molecule that protects epithelial cells from oxidative cell injury". The American Journal of Pathology. 185 (10): 2757–67. doi:10.1016/j.ajpath.2015.06.006. PMC 4607757. PMID 26342724.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000182271 - Ensembl, May 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000020839 - Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[entrez-5] "Entrez Gene: Transmembrane and immunoglobulin domain containing 1". Retrieved 2017-02-20.

[6] Meyer RD, Zou X, Ali M, Ersoy E, Bondzie PA, Lavaei M, et al. (February 2018). "TMIGD1 acts as a tumor suppressor through regulation of p21Cip1/p27Kip1 in renal cancer". Oncotarget. 9 (11): 9672–9684. doi:10.18632/oncotarget.23822. PMC 5839393. PMID 29515762.

[7] Arafa E, Bondzie PA, Rezazadeh K, Meyer RD, Hartsough E, Henderson JM, et al. (October 2015). "TMIGD1 is a novel adhesion molecule that protects epithelial cells from oxidative cell injury". The American Journal of Pathology. 185 (10): 2757–67. doi:10.1016/j.ajpath.2015.06.006. PMC 4607757. PMID 26342724.